These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 20185409
1. Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial. Chow KM, Lo SH, Szeto CC, Yuen SK, Wong KS, Kwan BC, Leung CB, Li PK. Nephrol Dial Transplant; 2010 Jul; 25(7):2303-9. PubMed ID: 20185409 [Abstract] [Full Text] [Related]
4. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients. Chanchairujira T, Chantaphakul N, Thanwandee T, Ong-Ajyooth L. J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452 [Abstract] [Full Text] [Related]
5. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Liu YL, Kao MT, Huang CC. Vaccine; 2005 Jun 10; 23(30):3957-60. PubMed ID: 15917117 [Abstract] [Full Text] [Related]
7. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization. Radziszewski A, Gajda M, Pituch-Noworolska A, Drozdz M, Kraśniak A, Kaczmarczyk I, Hołyś S, Zurowski J, Sydor A, Sułowicz W. Przegl Lek; 2007 Jun 10; 64(7-8):470-5. PubMed ID: 18409347 [Abstract] [Full Text] [Related]
11. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Micozkadioglu H, Zumrutdal A, Torun D, Sezer S, Ozdemir FN, Haberal M. Ren Fail; 2007 Jun 10; 29(3):285-8. PubMed ID: 17497441 [Abstract] [Full Text] [Related]
14. The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients. Dacko C, Holley JL. Adv Perit Dial; 1996 Jun 10; 12():315-7. PubMed ID: 8865927 [Abstract] [Full Text] [Related]
15. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed. Prescrire Int; 2008 Dec 10; 17(98):234-6. PubMed ID: 19422145 [Abstract] [Full Text] [Related]
16. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years. Gilbert CL, Klopfer SO, Martin JC, Schödel FP, Bhuyan PK. Hum Vaccin; 2011 Dec 10; 7(12):1336-42. PubMed ID: 22185811 [Abstract] [Full Text] [Related]
17. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. Di Paolo D, Lenci I, Trinito MO, Tisone G, Angelico M. Dig Liver Dis; 2005 Oct 10; 37(10):793-8. PubMed ID: 16024302 [Abstract] [Full Text] [Related]
18. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients. Sorkhi H, Dooki MR, Ebrahimnejad MS. J Med Assoc Thai; 2006 Oct 10; 89(10):1648-53. PubMed ID: 17128839 [Abstract] [Full Text] [Related]
20. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus JM. Hemodial Int; 2005 Oct 10; 9(4):367-75. PubMed ID: 16219057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]